Wild Meripilus giganteus Karst belongs to the order Polyporales, in which some members are known to possess a wide range of pharmacological properties. M. giganteus showed to be rich in carbohydrates (74.49 g/100 g) and proteins (15.94 g/100 g), presenting low fat content (1.51 g/100 g). Chemical composition was determined by using chromatographic techniques. Also, various bioactive compounds were detected including all four tocopherol isoforms with d-and g-tocopherols being predominant (123.35 and 77.80 mg/100 g, respectively); five organic acids (oxalic, malic, quinic, citric and fumaric acids) with predominant malic acid (3.17 g/100 g); and three phenolic acids and related compounds (phydroxybenzoic, p-coumaric and cinnamic acids; 1010, 2420 and 340 mg/100 g, respectively). M. giganteus methanolic extract exhibited antioxidant activity tested by five different assays with the strongest potential in TBARS assay (EC 50 0.31 mg/mL); and antimicrobial activities (MIC/MBC 0.0125e5 mg/mL; MIC/ MFC 0.025e0.4 mg/mL). Furthermore, treatment of cervical carcinoma cell line (HeLa) led to reduction in cell's viability in MTT assay (IC 50 0.41 mg/mL after 48 h), induced process of apoptosis and inhibited cell's migration in vitro. The analysed extract was not toxic for zebrafish embryos (at 0.5 mg/mL), indicating its biosafety and potential application as a dietary supplement in chemoprevention.
Introduction
Besides their high nutritional value (Kala c, 2013), mushrooms possess a wide variety of beneficial effects to human health, with special emphasis on pharmacological properties such as antioxidant (Ferreira, Barros, & Abreu, 2009) , antimicrobial (Alves et al., 2013) and antitumor (Popovi c, Zivkovi c, Davidovi c, Stevanovi c, & Stojkovi c, 2013) activities. Among the bioactive constituents in medicinal and edible mushrooms, tocopherols, fatty acids, organic acids, polyphenols, polysacharides and proteins are the most frequently reported. Bioactivity of tocopherols includes antioxidant capacity ) that confers ability to prevent diseases correlated with increased formation of free radicals and oxidative stress. Also, polyunsaturated fatty acids (PUFAs) seem to be endogenous mediators for cell signaling, being involved in the regulation of gene expression and other biological processes (Choque, Catheline, Rioux, & Legrand, 2014) . Furthermore, phenolic compounds are known to exert multiple biological effects, including antioxidant, antitumor, antimutagenic and antibacterial properties (Kancheva & Kasaikina, 2013) .
Reactions leading to the production of free radicals namely, reactive oxigen species (ROS), reactive nitrosative species (RNS) and reactive sulphur species (RSS) have been linked to many severe diseases, such as cancer. Therefore, searching for novel sources of antioxidants from natural origin, being able to neutralize free radicals, is one of the major concerns in the field of cancer chemoprevention. In addition, more than 15% of malignancies worldwide have been related to an infectious cause (Mager, 2006) . Although there are effective ways and reliable drugs to treat microbial infections, some bacteria and fungi develop mechanisms to overcome the effects of commercial antimicrobial agents, mostly due to their misuse. Proper treatment of microbial infections is leading to lower cancer occurrence and this should influence the well-being of human population (Assaf et al., 2013) . Additionally, mycotherapy of cancer is emerging as a rapidly growing and promising discipline that involves the study of cancer chemopreventive and anticancer properties of mushrooms extracts and their bioactive compounds (Popovi c et al., 2013) .
Meripilus giganteus Karst. is a wild growing basidiomycete with an edible fruiting body, belonging to the family Meripilaceae. It is a parasitic species on trees, being also characterized as saprobic. It is frequently found on Quercus and Fagus species, but it can also be found on some hardwoods and coniferous species. M. giganteus is mainly distributed in northern hemisphere, in Europe, Turkey, Iran and northern Asia (Schmidt, 2006) . So far, reports on chemical composition of M. giganteus growing wild in Serbia, as well as on bioactive properties of its methanolic extract are very scarce (Karaman, Jovin, Malba sa, Matavuly, & Popovic, 2010; Karaman, Kaisarevic, Somborski, Kebert, & Matavulj, 2009 ). The present study aims to characterize the chemical composition of M. giganteus and to evaluate its biological properties namely, antioxidant potential, antimicrobial activity and the effect on cancer cell's viability, apoptosis and migration in vitro. Finally, its toxicity was evaluated on zebrafish.
Materials and methods

Samples
The samples of wild growing Meripilus giganteus Karst. were collected in Boj cinska forest, Belgrade, Serbia, in autumn 2012, and authenticated by Dr. Jasmina Glamo clija (Institute for Biological Research). A voucher specimen was deposited at the Fungal Collection Unit of the Mycological Laboratory, Department for Plant Physiology, Institute for Biological Research "Sini sa Stankovi c", Belgrade, Serbia, under the number Mg 181 2012. The samples were lyophilized (LH Leybold, Lyovac GT2, Frenkendorf), reduced to a fine dried powder (20 mesh) and stored in a desiccator, protected from light, until further analysis.
Standards and reagents
Acetonitrile 99.9%, n-hexane 95% and ethyl acetate 99.8% were of HPLC grade from Fisher Scientific (Lisbon, Portugal). The fatty acids methyl ester (FAME) reference standard mixture 37 (standard 47885-U) was purchased from Sigma (St. Louis, MO, USA), as also were other individual fatty acid isomers, trolox (6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid), tocopherol and sugar standards. Phenolic compound standards were from Extrasynthese (Genay, France). Racemic tocol, 50 mg/mL, was purchased from Matreya (Pleasant Gap, PA, USA). 2,2-Diphenyl-1-picrylhydrazyl (DPPH) was obtained from Alfa Aesar (Ward Hill, MA, USA). Dulbecco's modified Eagle's medium (DMEM), fetal bovine serum (FBS) and MEM non-essential amino acids (NEAA) were obtained from Invitrogen (NY, USA). 3-(4,5-Dimethylthiazol-2yl)-2,5-diphenyltetrazolium bromide (MTT), paraformaldehyde (PFA) and dimethylsulfoxide (DMSO) were from Merck (KGaA, Germany). 4 0 ,6-Diamidino-2-phenylindole dihydrochloride (DAPI) and propidium iodide (PI) were obtained from Sigma (St. Louis, MO, USA) and doxorubicin from Pfizer Inc (NY, USA). APOPTEST™-FITC kit was obtained from Dako (Agilent Technologies Inc., Denmark). MuellereHinton agar (MH) and malt agar (MA) were obtained from the Institute of Immunology and Virology, Torlak (Belgrade, Serbia). Water was treated in a Milli-Q water purification system (TGI Pure Water Systems, Greenville, SC, USA).
Preparation of the M. giganteus methanolic extract
Samples (~5 g) were extracted by stirring with 150 mL of methanol (25 C at 150 rpm) for 1 h and subsequently filtered through Whatman No. 4 paper. The residue was then extracted with an additional portion of methanol. The combined methanolic extracts were evaporated under reduced pressure (rotary evaporator Büchi R-210; Flawil, Switzerland) to dryness (Heleno, Barros, Sousa, Martins, & Ferreira, 2010) . The extract was redissolved in i) methanol (final concentration 20 mg/mL) for antioxidant activity assays, ii) 30% EtOH (final concentration 1.5 mg/mL) for antimicrobial activity assays and for cytotoxic activity evaluation (80 mg/ mL final concentration). The final solutions were further diluted to different concentrations to be submitted to distinct bioactivity evaluation in vitro assays. The results were expressed in i) EC 50 values (sample concentration providing 50% of antioxidant activity or 0.5 of absorbance in the reducing power assay) for antioxidant activity; ii) MIC (Minimum inhibitory concentration) and MBC/MFC (Minimum bactericidal concentration/Minimum fungicidal concentration) values for in vitro antimicrobial activity iii) IC 50 value (sample concentration providing 50% inhibition of cell growth in MTT test) for cytotoxicity assay.
Chemical characterization of the M. giganteus methanolic extract -bioactive compounds
Tocopherols were determined following a procedure previously described by the authors (Heleno et al., 2010) using HPLCfluorescence. The compounds were identified by chromatographic comparisons with authentic standards. Quantification was based on the fluorescence signal response of each standard, using the IS (tocol) method and by using calibration curves obtained from commercial standards of each compound: a-tocopherol
The results were expressed in mg per 100 g of dry weight (dw). Organic acids were determined by ultrafast liquid chromatography coupled to a photodiode array detector (UFLC-PAD), following a procedure previously described by the authors (Barros, Pereira, & Ferreira, 2013 per 100 g of dry mushroom (dw). Phenolic compounds were determined by the same methodology using 280 nm and 370 nm as preferred wavelengths, according to a procedure previously described by the authors (Barros, Dueñas, Ferreira, Baptista, & Santos-Buelga, 2009 ). The phenolic compounds were characterized according to their UV and mass spectra and retention times, and comparison with authentic standards when available. For the quantitative analysis of phenolic compounds, a calibration curve was obtained by injection of known concentrations (5e80 mg/mL)
The results were expressed as mg per 100 g of dry weight (dw).
Antioxidant activity
DPPH radical-scavenging activity was evaluated by using an ELX800 microplate reader (Bio-Tek Instruments, Inc; Winooski, VT, USA), and calculated as a percentage of DPPH discolouration using the formula: [(A DPPH -A S )/A DPPH ] Â 100, where A S is the absorbance of the solution containing the sample at 515 nm, and A DPPH is the absorbance of the DPPH solution. Reducing power was evaluated by two different assays: Ferricyanide/Prussian blue assay, which determines the capacity to convert Fe 3þ into Fe 2þ , measuring the absorbance at 690 nm in the microplate reader mentioned above; Folin-Ciocalteu assay: the colour development was measured at 765 nm (Analytikjena spectrophotometer; Jena, Germany). Gallic acid was used to obtain the standard curve and the reduction of Folin-Ciocalteu reagent by the samples was expressed as mg of gallic acid equivalents (GAE) per g of extract (Heleno et al., 2010) .
Inhibition of b-carotene bleaching was evaluated though the bcarotene/linoleate assay; the neutralization of linoleate free radicals avoids b-carotene bleaching, measured at 470 nm and calculated by the formula: b-carotene absorbance after 2 h of assay/ initial absorbance) Â 100 (Heleno et al., 2010) . Lipid peroxidation inhibition in porcine (Sus scrofa) brain homogenates was evaluated by the decreasing in thiobarbituric acid reactive substances (TBARS); the colour intensity of the malondialdehydethiobarbituric acid (MDA-TBA) was measured by its absorbance at 532 nm; the inhibition ratio (%) was calculated using the following formula: [(A -B)/A] Â 100%, where A and B were the absorbances of the control and the sample solution, respectively (Heleno et al., 2010) . Trolox was used as a positive control in all of the antioxidant assays.
Antimicrobial properties
The following Gram-negative bacteria were used: Escherichia coli ( In order to investigate the antimicrobial activity of the M. giganteus methanolic extract, a modified microdilution technique was used (CLSI, 2009) . Minimum inhibitory concentration (MIC) determinations were performed by a serial dilution technique using 96-well microtiter plates. The minimum bactericidal concentrations (MBCs) and minimum fungicidal concentrations (MFCs) were determined by serial subcultivation of a 2 mL sample into microtiter plates containing 100 mL of broth per well and further incubation for 48 h at 37 C or 72 h at 28 C. The lowest concentration with no visible growth was defined as MBC/MFC, respectively, indicating 99.5% killing of the original inoculum. Streptomycin (streptomycin sulfate (ICN-Galenika, Belgrade, Serbia) and ampicillin (Panfarma, Belgrade, Serbia) were used as positive controls in antibacterial assay, while commercial fungicides, bifonazole (Srbolek, Belgrade, Serbia) and ketoconazole (Zorkapharma, Sabac, Serbia), were used as positive controls in antifungal tests (1 mg/ml in sterile physiological saline). 30% EtOH was used as a negative control.
Evaluation of cytotoxicity by MTT assay
Human cervical cancer cell line HeLa and human lung fibroblasts MRC-5 were cultured in DMEM supplemented with 1% NEAA and 10% FBS at 37 C in a humidified incubator with 5% CO 2 . Cell viability was determined by the colorimetric MTT assay. 
Double DAPI and PI staining of live cells
Control cells and cells treated with IC 50 and IC 80 concentrations of extract were grown for 24 and 48 h on coverslips in 6-well plates. After washing three times in phosphate buffered saline (PBS), the cells were incubated in PBS containing 1 mg/mL of DAPI and 5 mg/mL of PI for 10 min at RT. After staining, cells were washed three times in PBS and fixed with 4% PFA for 15 min. Cells were examined under the Zeiss Axiovert inverted fluorescent microscope (Carl Zeiss Foundation, Oberkochen, Germany) equipped with AxioVision4.8 software, using 365/550 nm excitation; the fluorescence emission was measured at 445 nm for DAPI and 605 nm for PI with a 20Â objective.
2.9. Detection of apoptosis by a double staining method with Annexin V-FITC and PI Apoptosis assays were conducted using the APOPTEST™-FITC kit according to the manufacturer's instructions. Briefly, control cells (treated with vehicle only) and cells treated with IC 50 concentration of extract for 48 h were washed twice with cold PBS, resuspended in 1 Â Binding Buffer at a concentration of1
Â 10 6 cells/mL and Annexin V-FITC and PI were added at the final concentrations of 25 ng/mL and 2.5 mg/mL, respectively. The cells were gently mixed, incubated for 10 min in the dark at RT, and immediately analyzed (within 1 h) by Partec CyFlow ® Space (Partec GmbH, Münster, Germany). The flow cytometer collected 100,000 events and analysis was performed using Flomax Software © Version 2.9.
2.10. Wound-scratch migration assay 3 Â 10 5 cells were plated in 35 mm dish, grown to confluence and treated with IC 50 (24 h) concentration of M. giganteus extract in serum reduced conditions (1% FCS in DMEM) for 12 h before wound was made. Confluent cell monolayer was scratched with a 200 ml tip, washed with serum-free medium to remove detached cells and finally fresh medium containing 1% FCS and M. giganteus extract was added. Cell migration into the wounded area was monitored using DM IL LED Inverted Microscope (Leica Microsystems, Wetzlar, Germany) and closure of the gap distance was quantified using Leica Application Suite V4.3.0.
In vivo zebrafish toxicity assay
Assay is described in detail in Supplementary material.
Statistical analysis
Three samples were used and all the assays were carried out in triplicate. The results are expressed as mean values ± standard deviation (SD) or standard error mean (SEM). The results were analyzed using one-way analysis of variance (ANOVA) followed by Tukey's HSD test with a ¼ 0.05 or Student's t-test. This analysis was carried out using SPSS 22.0 program.
Results and discussion
Chemical composition of M. giganteus methanolic extractbioactive compounds
Bioactive compounds (tocopherols, organic and phenolic acids) identified in M. giganteus are presented in Table 1 . All tocopherol isoforms were detected, but d-and g-tocopherols were the predominant isoforms (Table 1 and Fig. 1A ). On the other hand, b-and a-tocopherols were found at lower levels ( Table 1) . The most suitable sources of antioxidants, such as tocopherols, are provided by our diet, more than by antioxidant supplements (pills or tablets) (Bjelakovic, Nikolova, & Gluud, 2014) . M. giganteus represents a food source regarding intake of antioxidant tocopherols and to the best of our knowledge, tocopherols composition in this species was not previously reported in literature.
Quantitative values of organic acids identified in M. giganteus are given in Table 1 and its profile is represented in Fig. 1B . Malic acid, a dicarboxylic acid occurring naturally in all fruits, many vegetables and mushrooms, was the predominant organic acid, which was also observed for other mushroom species (Barros et al., 2013) . Oxalic, citric, quinic and fumaric acids were also identified and quantified. Health-beneficial effects and bioactive properties of some organic acids are well-known and include antimicrobial, antioxidant and acidifying properties. Our results are in accordance to those published for other mushroom species (Barros et al., 2013) .
Phenolic acids profile was provided in Fig. 1C p-Coumaric acid was the most abundant phenolic component identified in M. giganteus, while p-hydroxybenzoic and cinnamic acids were found at lower levels (Table 1) . A previous study performed by Karaman et al. (2010) reported gallic (675 mg/g) and protocatechuic (279 mg/g) acids as the only phenolic compounds in M. giganteus, while p-coumaric acid was not detected. The observed differences might be attributed to different extraction methodologies or different maturity stages of fruiting bodies, among other factors.
Nutritional value, sugars composition and fatty acids profile are presented in Supplementary material.
In vitro analysis of bioactive properties
In order to analyze bioactive properties of M. giganteus methanolic extract, we have investigated antioxidant activity, antimicrobial properties, and the effect on cancer cell's viability, apoptosis and migration in vitro. Finally, toxicity testing of M. giganteus methanolic extract was performed on zebrafish embryos and these results are presented in Supplementary material.
The antioxidant activity
Since natural matrices with antioxidant activity important for the discovery of novel cancer chemopreventive and chemotherapeutic agents, we have analyzed the antioxidant activity of M. giganteus methanolic extract by five different in vitro assays (Table 2) .
Total phenolics content in the methanolic extract was 58.20 mg GAE/g of extract which is higher than the one reported by Karaman et al. (2010) (5.11 mg of chlorogenic acid equivalents/g of dry weight of M. giganteus). The obtained difference might be related to the different extraction methods used. Lipid peroxidation inhibition, evaluated by the decreasing in TBARS formation, gave the best result with EC 50 value of 0.31 mg/mL. For Ferricyanide/Prussian blue assay, EC 50 value was 0.83 mg/mL. On the other hand, DPPH scavenging activity and inhibition of b-carotene bleaching gave slightly higher results with EC 50 values of 2.08 mg/mL and 2.14 mg/ mL, respectively. DPPH scavenging activity of M. giganteus 70% methanolic extract was previously evaluated and the EC 50 value was 0.155 mg/mL (Karaman et al., 2010) . In the present study, the EC 50 DPPH scavenging activity value was significantly higher compared to the mentioned report and this difference might be explained by the different extraction conditions and drying processes applied to mushrooms (e.g. drying in the oven at 50 C). As far as we know, this is the first study reporting antioxidant activity of pure methanolic extract of M. giganteus. The observed antioxidant activity may be related to the presence of phenolic acids and tocopherols, as generalized for other mushroom species ).
Antimicrobial properties
Antibacterial and antifungal activity of the M. giganteus extract was assessed by microdilution methods, and the results are presented as MIC and MBC/MFC in Table 3 . The most sensitive bacterial species to M. giganteus methanolic extract were S. aureus and B. cereus with the same MICs (0.0125 mg/mL) and MBCs (0.035 mg/ mL). E. cloacae strain was the most resistant to the effect of M. giganteus extract with MIC of 2.50 mg/mL and MBC of 5.00 mg/ mL. It should be noted that the most sensitive bacterial strains were Gram positive. Although, M. flavus (Gram positive) and P. aeruginosa (Gram negative) had the same inhibitory and bactericidal values (0.60 mg/mL and 1.25 mg/mL), it might be suggested that the antimicrobial activity is dependent on bacterial species used. The The results are expressed as IC 50 and IC 80 values corresponding to the extract/compound concentration, which inhibited 50% and 80% of cell growth after 24 and 48 h of treatment, respectively. Doxorubicin was used as a positive reference compound. Different letters (a, b) mean significant differences between extract and doxorubicin after 24 h and 48 h of treatment, respectively (p 0.05). Na-not acquired. activity of the extract decreased in order: Karaman et al. (2010) , even though applying different method, also found S. aureus strain as the most sensitive to the antimicrobial action of M. giganteus.
Regarding antifungal activity, A. versicolor and P. funiculosum were the most susceptible micromycetes with MICs of 0.025 mg/mL and MFCs of 0.050 mg/mL. A. niger was the most resistant strain with MIC of 0.30 mg/mL and MFC of 0.40 mg/mL. Antifungal activity of the tested sample decreased in order: A. versicolor ¼ P. funiculosum > T. viride > A. fumigatus > A. ochraceus ¼ P. ochrochloron ¼ P. aurantiogriseum > A. niger. In general, fungi were more sensitive than bacteria to the effect of M. giganteus extract. To the best of our knowledge, no previous studies reported antifungal activity of M. giganteus. Standard antibiotics (streptomycin and ampicillin) and antimycotics (bifonazole and ketoconazole) were used as positive controls, but comparison with M. giganteus extract should be avoided, since the extract presents a mixture of compounds in which the concentration of each bioactive compound is much lower than the MIC. Antimicrobial activity could be related to the presence of the phenolic acids identified in the extract that also show antimicrobial properties against bacteria and fungi (Heleno et al., 2013) .
Evaluation of cytotoxic properties on HeLa cells
The effect of M. giganteus methanolic extract on the proliferation and viability of HeLa cells was assessed using MTT assay. A dosedependent growth inhibition was observed in HeLa cell line after treatment with the extract for 24 h and 48 h. Extract concentrations required for 50% inhibition of growth (IC 50 ) were 0.72 mg/mL and 0.41 mg/mL for 24 and 48 h of treatment, respectively (Table 4) . The concentrations required for 80% of growth inhibition (IC 80 ) were 1.32 mg/mL and 0.80 mg/mL for 24 h and 48 h, respectively. These results are consistent with two previously published showing that M. giganteus methanolic extract displays cytotoxicity against human breast carcinoma cells MCF-7 (with similar range of IC 50 concentrations) and against murine Lewis lung carcinoma cell line 3LL (Karaman et al., 2009; Tomasi, Lohezic-Le Devehat, Sauleau, Bezivin, & Boustie, 2004) . Methanolic extract of M.giganteus did not cause 50% inhibition of growth (IC 50 ) of normal fibroblast cell line MRC-5, even at the highest concentration tested (1.6 mg/mL, Table 4 ). These results suggest the presence of bioactive compounds that impair cell growth in the analyzed extract. The identified phenolic acids could be, at least partly, responsible for this property. pCoumaric acid, most abundant phenolic component of M. giganteus methanolic extract, was previously shown to inhibit proliferation and induce apoptosis of colorectal adenocarcinoma cell lines (HCT-15 and HT-29) (Jaganathan, Supriyanto, & Mandal, 2013) . Cytotoxic activity on several malignant cell lines was also demonstrated for cinnamic acid and its derivatives (Sova et al., 2013) .
Induction of apoptosis of HeLa cells
First we have observed morphological changes in HeLa cells nuclei after treatment with M. giganteus extract using double staining with DAPI and PI. Cells treated with M. giganteus extract for 24 or 48 h exhibited typical features of apoptosis such as nuclear condensation, fragmentation and formation of apoptotic bodies ( Fig. 2A) . Cells in early apoptosis have highly condensed chromatin that is characterized by more intense blue fluorescence compared to the nuclei of healthy cells, while cells in late apoptosis/necrosis have lost the integrity of their plasma membranes and their condensed/fragmented chromatin is characterized by bright red fluorescence. Observed morphological changes suggest that mechanism underlying inhibition of cell growth by M. giganteus extract relies on induction of apoptosis. This mode of action has been demonstrated previously for many mushroom extracts and their bioactive principles (Popovi c et al., 2013) .
These results were confirmed by flow cytometry (Fig. 2B and C) . Obtained results suggested that M. giganteus methanolic extract induced early apoptosis in HeLa cells (Annexinþ/PIÀ). Based on three independent experiments the percentage of cells in early apoptosis raised to 17% compared to control cells treated with vehicle only (Fig. 2C) . At the same time, the low percentage of cells with necrosis (AnnexinÀ/PIþ) and late apoptosis (Annexinþ/PIþ) remained unchanged. Taken together, these results suggest that M. giganteus extract induced apoptosis of HeLa cells.
The effect on migratory potential of HeLa cells
Since the ability of cancer cells to migrate is closely associated with their capacity to colonize distant organs, we tested migratory potential of HeLa cells, upon treatment with M. giganteus extract, using wound scratch assays. We detected that treated HeLa cells were slower in closing the scratched area than control cells (Fig. 3) , showing that M. giganteus extract exhibits not only cytotoxic, but also antimigratory effect on HeLa cells.
Antimigratory potential of mushroom's extracts has been reported for other classes like Fomitopsis pinicola which belongs to the Basidiomycota fungal class that could inhibit the migration of colon cancer cell line SW-480 (Wang et al., 2014) , or Ganoderma lucidum that exerts strong antimigratory effect on ovarian cancer cell lines (Zhao et al., 2011) . This is the first report presenting antimigratory potential of M. giganteus extract on cancer cells in vitro.
Conclusions
Chemical composition analysis of M. giganteus methanolic extract revealed the presence of bioactive compounds (all tocopherol isoforms, five organic and three phenolic acids) along with carbohydrates, fatty acids and proteins. Trehalose was identified as the predominant free sugar. Polyunsaturated fatty acids predominated over monounsaturated and saturated fatty acids, highlighting linoleic acid as the most dominant one. M. giganteus is a natural source of agents exhibiting antioxidant, antimicrobial and antitumor activities highlighting this species as a valuable dietary supplement in chemoprevention. Importantly, M. giganteus extract was not toxic for zebrafish embryos indicating its biosafety and potential for further applications in food or pharmaceutical industry.
